Alzheimer's Disease (AD) is the most common subtype of dementia. As the prevalence of dementia is projected to increase, the burden of the disease on society is expected to become increasingly significant. The link between eye pathology and neurodegenerative diseases has been established in multiple studies. In particular, optic nerve parameters associated with neuronal loss in AD include retinal ganglion cells (RGC). Retinal ganglion cells are similar to neurons in the cerebral cortex, and have been correlated to neurodegeneration in AD. Ocular imaging techniques such as optical coherence tomography (OCT) have provided a rapid and non-invasive method for quantifying optic nerve parameters in vivo. Spectral domain (SD)-OCT has shown good potential in the study of the optic nerve in AD as it enables more comprehensive assessment of RGCs. Earlier generation OCT techniques only assess the retinal nerve fibre layer, which consists of RGC axons. Spectral domain-OCT offers ultra-high scan speed and image resolution, enabling improved sampling of retinal layers. Retinal layers such as the ganglion cell-inner plexiform layer (GC-IPL), which contain the dendrites and nuclei of RGCs, can be assessed with SD-OCT. This article presents a review of literature associating eye pathology with AD, and explores the potential of SD-OCT in future AD studies. Spectral domain-OCT has the potential to draw more links between optic nerve pathology and neurodegeneration.
INTRODUCTION
Dementia is of growing medical, social and economic concern globally, afflicting an estimated 35.6 million people worldwide in 2010, with figures projected to rise to 65.7 million by 2030 and 115.4 million by 2050 1 . In Singapore, dementia is a rising public health issue as Singapore has a rapidly ageing population, with the proportion of elderly (aged 65 and above) estimated to increase from 7% in 1999 to 19-20% by 2030 2, 3 . As such, the prevalence of dementia in Singapore is expected to increase from 0.65% in 2010 to 3.6% in 2050 4 . Alzheimer's Disease (AD) is the most common subtype of dementia, accounting for approximately 60% of cases 5, 6 . With an increasing prevalence of dementia in Singapore, the burden of disease on our healthcare service, society and economy is likely to be significant.
An increasing number of studies have begun to draw the link between neurodegenerative diseases and eye pathology, suggesting that studying the visual system may shed more light on neurodegenerative diseases. The retina and optic nerve share the same embryological origin as the brain areas responsible
Proceedings of Singapore Healthcare  Volume 23  Number 1  2014 for cognitive function 7, 8 . Homology between retinal and brain microvasculature is such that changes in cerebral vasculature can be reflected in the retinal vasculature 7 , with retinal microvascular abnormalities shown to be associated with cognitive impairment 9, 10 . Ocular manifestations of neuropathology have been observed to precede brain pathological changes in many central nervous system (CNS) disorders, suggesting a means of early diagnosis.
In the study of neurodegenerative diseases and the eye, retinal ganglion cells (RGCs) are of particular interest as they are neuronal cells. Early neuropathological studies have drawn a link between RGC and AD, showing RGC loss in AD patients 11 . Other optic nerve manifestations in AD have been found in later studies, such as reduction in retinal nerve fibre layer (RNFL) thickness and RGC loss [12] [13] [14] [15] . Aside from AD, ocular manifestations can also be seen in other CNS disorders. Some examples include RNFL thinning and optic nerve neurodegeneration in stroke 16 , RGC degeneration and RNFL thinning in multiple sclerosis 17, 18 , as well as swelling of photoreceptors and RNFL thinning in Parkinson's Disease [19] [20] [21] [22] [23] . Hence, the optic nerve has emerged as a possible tool for observing neurodegenerative processes occurring in the brain. Using newly derived ocular imaging techniques, optic nerve parameters can be quantified in detail. This would allow observation of both the physiological and functional impact of dementia on the visual system, allowing further insight into the pathophysiology of cerebral neurodegenerative processes.
Of the variety of ocular imaging techniques now available, optical coherence tomography (OCT) has emerged to the forefront with its high speed, high resolution, and capability to analyze the retina and optic nerve in vivo. The recent development of the spectral-domain OCT (SD-OCT) has considerable advantages over earlier generation time-domain OCT (TD-OCT). The SD-OCT is able to identify intraretinal layers such as the RGC layer, enabling the quantification of more detail in the retina and optic nerve that are useful in studying AD. In this article, we discuss the potential of the SD-OCT as a tool to observe neurodegeneration in AD.
OCULAR MANIFESTATIONS OF AD
Alzheimer's Disease is a neurodegenerative disease that is commonly associated with memory and cognitive defects, including short-term memory deterioration, impaired cognitive function and reduced emotional control 6, 24 . In AD, some of the observed neuropathologic changes include atrophy of the hippocampus, deposition of amyloid plaques and neurofibrillary tangles in the neocortex, hippocampus, amygdala and basal nucleus of Meynert 25, 26 .
Early studies of the brain have started to draw close links between the visual system and the brain. Amyloid-beta plaques were found to be present in the visual association cortex of AD patients and even cognitively intact persons diagnosed with preclinical AD [27] [28] [29] [30] . Furthermore, neurofibrillary tangles tend to be located in the visual association areas [28] [29] [30] . Thus, it has been hypothesised that AD pathology may originate in the visual association area instead of the hippocampus, suggesting that visual function loss may serve as an early indication of AD. However, of all the components of the visual system, research has mainly focused on the link between the retina and AD.
A number of pathological changes in the retina, optic disc and optic nerve have been found to be associated with AD. Retinal ganglion cells are responsible for consolidating information from the photoreceptors and surrounding cells, before passing on visual information received to the brain via the optic nerve. Although RGC depletion is typically associated with loss of vision in glaucoma [31] [32] [33] [34] [35] , since RGCs are similar to neurons in the cerebral cortex, RGC degeneration is also expected to be present in other neurodegenerative diseases such as AD 36, 37 . Post mortem studies by Hinton et al 11 first reported histopathological evidence of widespread axonal degeneration in the RGC layer and RNFL of the optic nerve in AD patients. Retinal ganglion cell loss in AD patients has been linked to deterioration of visual function. Additionally, mouse models show that RGC dendritic degeneration may possibly be a sensitive marker for neural damage in AD 38 . While the RGC layer shows good potential in assessing neurodegeneration in AD, this has not been fully exploited due to lack of high-resolution imaging of the retinal layers.
In vivo observations of optic neuropathy may be useful in early identification of AD and assessment of neurodegeneration. Advancing from histopathological studies, fundus photography was later used in retinal studies of AD. A study conducted by Tsai et al 39 found a significant correlation between cup-to-disc ratio, cup volume and disc rim area with Alzheimer's Disease Assessment Scale (ADAS) scores and duration of disease. However, the method of optic nerve head (ONH) analysis in this study has certain disadvantages, as it is manual and highly subjective to each individual observer. The use of automated image processing programs to analyse the ONH would be more effective in addressing these limitations.
ASSESSMENT OF THE OPTIC NERVE IN AD USING ADVANCED OCULAR IMAGING TECHNOLOGY
Studies on ocular manifestations of AD have been conducted with various imaging techniques. Currently, commercially available ocular imaging techniques include OCT, confocal scanning laser ophthalmoscopy (CSLO) using the Heidelberg Retinal Tomograph (HRT) and scanning laser polarimetry (SLP) using the GDx Variable Corneal Compensator (VCC) 40 . These imaging technologies allow the cross-sectional imaging of the retina and ONH in vivo, allowing quantitative analysis of the RNFL, ONH and macula.
Optical coherence tomography is an optical imaging technique that performs high resolution tomographic imaging of biological tissues 41 , providing a non-invasive biopsy of retinal tissue morphology. Optical coherence tomography technology utilises a low-coherence light source near the infra-red spectrum to penetrate biological tissue, forming an image of the tissue based on the backscattering of light or the time taken for the light to travel back to the lens, with varying signal intensities. Axial scans are continuously taken of the tissue to obtain a complete cross-sectional image of the tissue.
Optical coherence tomography has been widely used clinically in glaucoma and retinal disease detection, such as macular edema and agerelated macular degeneration 42 . Previous studies using the TD-OCT 14, 15, [43] [44] [45] [46] , CSLO 47 and SLP 48 have found optic nerve changes in AD when compared against age-matched controls. Some of these imaging studies have found significant reduction in RNFL and macular thickness 15, 43 , as well as optic nerve damage in AD patients compared to healthy controls 11, 14, 43, 44 . Several studies have found significant RNFL thickness reduction in the superior and inferior quadrants 14, 46 , while others have found significant reductions in all quadrants 15, 43 (superior, nasal, inferior, temporal). A similar trend was also observed in patients with mild cognitive impairment (MCI), defined as slight impairment in cognitive function greater than expected for an individual's age but with no notable interference with daily activities 49, 50 , generally considered as a preclinical stage to AD. Patients with MCI were found to have RNFL thinning in the inferior quadrant 46 , suggesting that changes in the optic nerve pathology may occur in early stages of AD.
Of the ocular imaging techniques available, TD-OCT has been most widely utilised to assess optic nerve degeneration in AD. While the TD-OCT has shown promising results in assessing RNFL reduction in AD, it has certain limitations, such as the resolution of TD-OCT scans being insufficient to demarcate and quantify the RGC layer reliably. As a result, many studies have yet to tap into the potential of the RGC layer as a tool to assess neuronal loss in AD.
SD-OCT
Recent advancement in OCT technology has gradually shifted the focus from TD-OCT to SD-OCT, which offers improved performance. The main difference between both systems is the movement of the reference mirror. In TD-OCT, the reference mirror is displaced and scanned mechanically over a distance to obtain depth scans. This reference mirror is immobilised in the SD-OCT. Spectral domain-OCT employs a different detection scheme from the TD-OCT, using a single spectrometer with a dispersive element such as diffraction grating. This allows broadband interference to be acquired using a broadband source. The single spectral measurement detected then undergoes Fourier transformation, which allows axial depth scans to be obtained without mechanically scanning the reference mirror, thus increasing scan speed 51 . The signal-to-noise ratio of SD-OCT is also independent of both bandwidth and scan depth, giving it improved sensitivity over TD-OCT 52 . In SD-OCT, higher spatial resolution is achievable with increased source bandwidth, which is not possible in TD-OCT, as increased source bandwidth would decrease signal-to-noise ratio 51 and reduce sensitivity. The SD-OCT can achieve a higher axial scan rate with greater scan depth, which is highly desired in OCT systems.
Spectral domain-OCT offers ultra-high scan speed and image resolution, providing depth resolution to a few microns, allowing improved sampling of retinal tissue layers and three-dimensional mapping [53] [54] [55] (Fig. 1) . Spectral domain-OCT can produce a 6 mm by 6 mm scan of the optic disc in 1.48 seconds with its improved scan speed. Three-dimensional models of the ONH can also be obtained, allowing better visualisation of retinal pathology and quantification of parameters such as RNFL thickness and neuroretinal rim area. In addition, improved axial resolution enables more reliable measurement and visualisation of detailed intra-retinal layers.
Spectral domain-OCT techniques have not been widely used in the study of AD, but a few studies which have started to employ the use of SD-OCT to access RNFL and RNFL+GCL thickness in casecontrol studies have shown promising results. Kirbas et al 56 has reported significantly reduced average RNFL thickness in patients at early stages of AD, with selective thinning in the superior quadrant, compared to healthy controls. Marziani et al 57 has likewise reported reduced RNFL and RNFL+GCL thickness in AD patients, as compared to cognitively normal controls matched for age and sex. Such findings are consistent with previous TD-OCT studies. Currently, we are unable to derive conclusive differences between the findings of studies using SD-OCT and TD-OCT due to the lack of sufficient data from AD studies using SD-OCT. Additionally, these studies have not used the high-resolution imaging of the SD-OCT to assess the ganglion cell-inner plexiform layer (GC-IPL) independently of the RNFL, which has potential as a more sensitive indication of neuronal loss in AD. Figure 2 shows evidence of RNFL thinning observed in AD patients, using Carl Zeiss Meditec Cirrus TM HD-OCT. Image analysis and quantitative optic nerve parameters were obtained by the built-in review software. The software carries out automated segmentation of the RNFL, quantifying the RNFL thickness map (6 mm by 6 mm) and average RNFL thickness, thickness per quadrant (superior, temporal, inferior, nasal) and per 12-clock-hours along the calculation circle (3.14 mm diameter), as well as a series of ONH parameters (e.g. optic disc area, neuroretinal rim area and cup-to-disc ratio). The software also allows the comparison of RNFL thickness against a normative database present within the software, highlighting abnormalities if RNFL thickness is lower than the fifth percentile of the normative population. Abnormal RNFL thickness is highlighted in yellow if the reading is lower than the fifth percentile of the normative population, and highlighted in red if it is lower than the first percentile. Readings within the 95th percentile of the population are considered normal and coloured green.
RNFL ANALYSIS USING SD-OCT
Based on the RNFL analysis report from an AD patient (Fig. 2) , Retinal nerve fibre layer abnormalities can be observed in both eyes. The average RNFL thickness of the right eye is highlighted in yellow and that of the left eye is red, indicating that the average RNFL thickness of each eye is lower than the fifth and first percentile of the normative population respectively. Detailed analysis of the RNFL quadrants shows that RNFL thinning is apparent in the superior quadrant of the right eye, and the superior, nasal and inferior quadrants of the left eye. These findings remain consistent with earlier TD-OCT studies, which have generally associated RNFL thinning with neurodegeneration in AD.
GC-IPL ANALYSIS
One of the main advantages of the SD-OCT over the TD-OCT is the increased axial resolution, which provides clearer and more reliable identification and quantification of intra-retinal layers. Some of the retinal layers of interest include the ganglion cell and inner plexiform layers 54 ( Fig. 3) , which could not be reliably identified and clearly demarcated using the TD-OCT. The ganglion cell layer is located near the surface of the retina and consists of the nuclei of RGCs. The inner plexiform layer is located below the ganglion cell layer, and contains the dendrites of RGC. In past studies, the reduced resolution of the TD-OCT could only allow Fig. 2 . Retina nerve fibre layer (RNFL) analysis report of an AD patient reflecting varying parameters including topological display of RNFL, deviation from normative data and thickness analysis by quadrant; figures in yellow and red (see online version of article) indicate RNFL thickness (average, quadrant or clock hours) to be lower than fifth and first percentile of normative population respectively. RNFL thinning is apparent in multiple quadrants, as well as in the average RNFL of both eyes.
the quantification of the RNFL, which only consists of the axons of RGCs. With the improved resolution of the SD-OCT, assessment of the GC-IPL can be carried out in addition to RNFL analysis. This allows a full assessment of the RGC density present in the retina and hence provides a more comprehensive picture of retinal neuronal loss. Figure 4 shows evidence of GC-IPL thinning in an AD patient. In the GC-IPL analysis, the review software of the SD-OCT detects the macula region and lays a grid over it, carrying out automatic segmentation of the macula into six sectors. The quantification of the GC-IPL layer is carried out at the macula where the RGC population is the densest, with approximately 50% of the RGCs located in this region. The grid is centred at the fovea, at which RGCs are absent, and quantification of the layer is done on the surrounding macula region. Similar to the RNFL analysis, the average thickness of the GC-IPL layer is measured in microns, as well as the thickness per sector. Abnormalities in thickness are highlighted in red and yellow. Based on the GC-IPL analysis of the AD patient (Fig. 4) , thinning of the GC-IPL is apparent based on the yellow-and red-coloured sectors of the macula of both eyes, which indicate deviation from the normative data.
In addition, the average GC-IPL thickness of the left eye is also thinner than the fifth percentile of the normative population.
FUTURE DIRECTIONS
Spectral domain-OCT offers a significant advantage in ophthalmology studies over the TD-OCT, allowing the study of additional retinal parameters such as RGCs, which could be more sensitive than current parameters used in AD retinal studies. Spectral domain-OCT has shown promising results based on RNFL and GC-IPL analyses, identifying the presence of RGC and optic nerve damage in AD. More recently, SD-OCT technology has been used in studies of other CNS and neurodegenerative disorders such as Parkinson's disease [58] [59] [60] and multiple sclerosis 61 , to evaluate retinal parameters including RNFL thickness, inner retinal layer thickness and macular thickness. There is definitely potential for this technology to be used in further studies of neurodegenerative diseases.
Furthermore, SD-OCT enables clearer identification and demarcation of retinal layers with the improved scan resolution. This function allows follow-up of modifications in retinal pathology of patients to be tracked, an improvement from TD-OCT. Past studies Fig. 3 . Clear demarcation of detailed retinal layers including the nerve fibre layer, ganglion cell layer and inner plexiform layers using the SD-OCT.
Review
Proceedings of Singapore Healthcare  Volume 23  Number 1  2014 using OCT imaging mainly had small sample sizes and were cross-sectional in design 14, 15, [43] [44] [45] [46] , but longitudinal studies are essential in order to assess the aetiological, diagnostic and predictive value of retinal changes for AD. With a tracking function, longitudinal studies tracking the changes in retinal parameters over time can be carried out, allowing the predictive ability of retinal changes in AD development to be assessed. The rapid scan acquisition speed of SD-OCT also allows better patient cooperation from patients with MCI or dementia.
Constant advancement in OCT techniques can improve the quality of ocular imaging in AD, providing new qualitative and quantitative data that may provide new information for assessing neurodegeneration in AD. The development of the swept source OCT (SS-OCT) addresses some of the limitations of the SD-OCT, including the reduced signal strength and image quality in patients with ocular opacities. SS-OCT and SD-OCT, which are classified as Fourier domain OCT techniques, have higher scans speeds than the TD-OCT as the need for mechanical depth scanning is eliminated 62 . Depth scans, or axial scans, can be calculated using a Fourier-transform of the spectra, thus improving scan speeds of both SS-OCT and SD-OCT. Hence, Fig. 4 . Ganglion cell-inner plexiform layer (GC-IPL) analysis report of an AD patient reflecting GC-IPL thickness maps, deviation from normative data and sector maps; figures in yellow and red (see online version of article) indicate GC-IPL thickness (average or sector) to be lower than fifth and first percentile of normative population respectively. GC-IPL thinning is apparent in multiple sectors of both eyes.
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Swept source-OCT also has an improved signalto-noise ratio as compared to TD-OCT 64 , providing scans of higher resolution. SD-OCT utilises a broadband light source, while the SS-OCT "sweeps" a narrow band laser through a broad optical bandwidth, obtaining time-encoded spectral information. Hence, the setup of the SS-OCT is simpler as it uses a single photodiode detector instead of the spectrometer needed to detect the spectral information in SD-OCT 65 . With the absence of the spectrometer, the SS-OCT has higher detection efficiency as the spectrometer grating losses are eliminated 66 . In addition, the SS-OCT has further advantages over the SD-OCT, including increased sensitivity with imaging depth, reduced fringe washout and longer imaging range 66 . Additionally, it allows higher penetration into the ONH and choroid as well as lowered sensitivity to ocular opacities [67] [68] [69] [70] . This is essential in assessing parameters in dementia patients, who tend to be older and more likely to have more ocular opacities.
Adaptive optics (AO) is another form of technology that can be used in combination with OCT by providing improved lateral scan resolution. Adaptive optics technology measures ocular aberrations in real-time using a wavefront sensor and corrects for these errors with a wavefront corrector 71 . This complements the high axial resolution of OCT scans, improving overall scan resolution. In addition to improved lateral resolution, AO reduces speckle size and increases sensitivity to weak reflections 71 . Using AO-OCT systems, volume images of retinal structures including retinal nerve fibre bundles, retinal capillaries, cone photoreceptors, microstructures in the ganglion cell layer and the lamina cribrosa 71 can be obtained in detail. By using AO-OCT techniques, more qualitative and quantitative parameters of the retina can be investigated in greater detail.
The development of the SD-OCT offers a highresolution, high-speed imaging technique that has shown potential in improving the understanding of dementia. Aside from applying this technique in the diagnosis of retinal diseases, it may also enhance the understanding of the role of retinal involvement in neurodegenerative disease progression.
In summary, the use of SD-OCT or future OCT techniques may be potentially useful in assessing neuronal loss in AD, allowing evaluation of disease progression even in preclinical stages, as well as evaluating treatment in clinical trials.
